The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Using Smartphones and Machine Learning to Quantify Parkinson Disease Severity: The Mobile Parkinson Disease Score
Open accessAbstract
Importance: Current Parkinson disease (PD) measures are subjective, rater-dependent, and assessed in clinic. Smartphones can measure PD features, yet no smartphone-derived rating score exists to assess motor symptom severity in real-world settings. Objectives: To develop an objective measure of PD severity and test construct validity by evaluating the ability of the measure to capture intraday symptom fluctuations, correlate with current standard PD outcome measures, and respond to dopaminergic therapy. Design, Setting, and Participants: This observational study assessed individuals with PD who remotely completed 5 tasks (voice, finger tapping, gait, balance, and reaction time) on the smartphone application. We used a novel machine-learning-based approach to generate a mobile Parkinson disease score (mPDS) that objectively weighs features derived from each smartphone activity (eg, stride length from the gait activity) and is scaled from 0 to 100 (where higher scores indicate greater severity). Individuals with and without PD additionally completed standard in-person assessments of PD with smartphone assessments during a period of 6 months. Main Outcomes and Measures: Ability of the mPDS to detect intraday symptom fluctuations, the correlation between the mPDS and standard measures, and the ability of the mPDS to respond to dopaminergic medication. Results: The mPDS was derived from 6148 smartphone activity assessments from 129 individuals (mean [SD] age, 58.7 [8.6] years; 56 [43.4%] women). Gait features contributed most to the total mPDS (33.4%). In addition, 23 individuals with PD (mean [SD] age, 64.6 [11.5] years; 11 [48%] women) and 17 without PD (mean [SD] age 54.2 [16.5] years; 12 [71%] women) completed in-clinic assessments. The mPDS detected symptom fluctuations with a mean (SD) intraday change of 13.9 (10.3) points on a scale of 0 to 100. The measure correlated well with the Movement Disorder Society Unified Parkinson Disease's Rating Scale total (r = 0.81; P < .001) and part III only (r = 0.88; P < .001), the Timed Up and Go assessment (r = 0.72; P = .002), and the Hoehn and Yahr stage (r = 0.91; P < .001). The mPDS improved by a mean (SD) of 16.3 (5.6) points in response to dopaminergic therapy. Conclusions and Relevance: Using a novel machine-learning approach, we created and demonstrated construct validity of an objective PD severity score derived from smartphone assessments. This score complements standard PD measures by providing frequent, objective, real-world assessments that could enhance clinical care and evaluation of novel therapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Timed “Up & Go”: A Test of Basic Functional Mobility for Frail Elderly Persons
Podsiadlo, D., & Richardson, S. (1991) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1991.tb01616.x · Cited by 14,418
Parkinsonism: onset, progression, and mortality
Hoehn, M. M., & Yahr, M. D. (1967) · Neurology · doi:10.1212/wnl.17.5.427 · Cited by 12,107
Goetz, C. G., Tilley, B. C., Shaftman, S. R., Stebbins, G. T., Fahn, S., Martinez‐Martin, P., Poewe, W., Sampaio, C., Stern, M. B., Dodel, R., et al. (2008) · Movement Disorders · doi:10.1002/mds.22340 · Cited by 7,536
Overdependence on degraded gist memory in Alzheimer's disease.
Gallo, D. A., Shahid, K. R., Olson, M. A., Solomon, T. M., Schacter, D. L., & Budson, A. E. (2006) · Neuropsychology · doi:10.1037/0894-4105.20.6.625 · Cited by 4,732
Adams, J. L., Dinesh, K., Xiong, M., Tarolli, C. G., Sharma, S., Sheth, N., Aranyosi, A. J., Zhu, W., Goldenthal, S., Biglan, K. M., et al. (2017) · Digital Biomarkers · doi:10.1159/000479018 · Cited by 3,171
Self-citationTechnology in Parkinson’s disease: challenges and opportunities
Espay, A. J., Bonato, P., Nahab, F. B., Maetzler, W., Dean, J. M., Klucken, J., Eskofier, B. M., Merola, A., Horak, F., Lang, A. E., et al. (2016) · Movement Disorders · doi:10.1002/mds.26642 · Cited by 654
Self-citationThe Parkinson Study Group QE3 Investigators, Beal, M. F., Oakes, D., Shoulson, I., Henchcliffe, C., Galpern, W. R., Haas, R., Juncos, J. L., Nutt, J. G., Voss, T. S., et al. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.131 · Cited by 408
Detecting and monitoring the symptoms of Parkinson's disease using smartphones: A pilot study
Arora, S., Venkataraman, V., Zhan, A., Donohue, S., Biglan, K. M., Dorsey, E. R., & Little, M. A. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.02.026 · Cited by 387
Self-citationParkinson's disease severity levels and MDS-Unified Parkinson's Disease Rating Scale
Martínez-Martín, P., Rodríguez-Blázquez, C., Alvarez, M., Arakaki, T., Arillo, V. C., Chaná, P., Fernández, W., Garretto, N., Martínez-Castrillo, J. C., Rodríguez-Violante, M., et al. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2014.10.026 · Cited by 360
A Validated Smartphone-Based Assessment of Gait and Gait Variability in Parkinson’s Disease
Ellis, R. J., Ng, Y. S., Zhu, S., Tan, D. M. L., Anderson, B., Schlaug, G., & Wang, Y. (2015) · PLoS ONE · doi:10.1371/journal.pone.0141694 · Cited by 160
Cited by
Bloem, B. R., Okun, M. S., & Klein, C. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00218-x · Cited by 3,920
Gait impairments in Parkinson’s disease
Mirelman, A., Bonato, P., Camicioli, R., Ellis, T. D., Giladi, N., Hamilton, J. L., Hass, C. J., Hausdorff, J. M., Pelosin, E., & Almeida, Q. J. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(19)30044-4 · Cited by 821
Sex and gender differences and biases in artificial intelligence for biomedicine and healthcare
Cirillo, D., Catuara-Solarz, S., Morey, C., Guney, E., Subirats, L., Mellino, S., Gigante, A., Valencia, A., Rementeria, M. J., Chadha, A. S., et al. (2020) · npj Digital Medicine · doi:10.1038/s41746-020-0288-5 · Cited by 553
Degenerative cervical myelopathy — update and future directions
Badhiwala, J. H., Ahuja, C. S., Akbar, M. A., Witiw, C. D., Nassiri, F., Furlan, J. C., Curt, A., Wilson, J. R., & Fehlings, M. G. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-019-0303-0 · Cited by 540
Digital biomarkers for Alzheimer’s disease: the mobile/wearable devices opportunity
Kourtis, L. C., Regele, O. B., Wright, J. M., & Jones, G. B. (2019) · npj Digital Medicine · doi:10.1038/s41746-019-0084-2 · Cited by 476
Artificial intelligence in clinical and genomic diagnostics
Dias, R., & Torkamani, A. (2019) · Genome Medicine · doi:10.1186/s13073-019-0689-8 · Cited by 456
AI in Health: State of the Art, Challenges, and Future Directions
Wang, F., & Preininger, A. (2019) · Yearbook of Medical Informatics · doi:10.1055/s-0039-1677908 · Cited by 398
Developing and adopting safe and effective digital biomarkers to improve patient outcomes
Coravos, A., Khozin, S., & Mandl, K. D. (2019) · npj Digital Medicine · doi:10.1038/s41746-019-0090-4 · Cited by 361
Inan, O. T., Tenaerts, P., Prindiville, S. A., Reynolds, H. R., Dizon, D. S., Cooper-Arnold, K., Turakhia, M., Pletcher, M. J., Preston, K. L., Krumholz, H. M., et al. (2020) · npj Digital Medicine · doi:10.1038/s41746-020-0302-y · Cited by 329
Espay, A. J., Hausdorff, J. M., Sánchez‐Ferro, Á., Klucken, J., Merola, A., Bonato, P., Paul, S. S., Horak, F. B., Vizcarra, J. A., Mestre, T. A., et al. (2019) · Movement Disorders · doi:10.1002/mds.27671 · Cited by 321
Self-citationLong-term unsupervised mobility assessment in movement disorders
Warmerdam, E., Hausdorff, J. M., Atrsaei, A., Zhou, Y., Mirelman, A., Aminian, K., Espay, A. J., Hansen, C., Evers, L. J. W., Keller, A., et al. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(19)30397-7 · Cited by 306
Lonini, L., Dai, A., Shawen, N., Simuni, T., Poon, C., Shimanovich, L., Daeschler, M., Ghaffari, R., Rogers, J. A., & Jayaraman, A. (2018) · npj Digital Medicine · doi:10.1038/s41746-018-0071-z · Cited by 209
Traditional and Digital Biomarkers: Two Worlds Apart?
Babrak, L. M., Menetski, J., Rebhan, M., Nisato, G., Zinggeler, M., Brasier, N., Baerenfaller, K., Brenzikofer, T., Baltzer, L., Vogler, C., et al. (2019) · Digital Biomarkers · doi:10.1159/000502000 · Cited by 181
Mahadevan, N., Demanuele, C., Zhang, H., Volfson, D., Ho, B., Erb, M. K., & Patel, S. (2020) · npj Digital Medicine · doi:10.1038/s41746-019-0217-7 · Cited by 138
Machine learning to assist clinical decision-making during the COVID-19 pandemic
Debnath, S., Barnaby, D. P., Coppa, K., Makhnevich, A., Kim, E. J., Chatterjee, S., Tóth, V., Levy, T. J., Paradis, M. D., Cohen, S. L., et al. (2020) · Bioelectronic Medicine · doi:10.1186/s42234-020-00050-8 · Cited by 104
Taylor, K. I., Staunton, H., Lipsmeier, F., Nobbs, D., & Lindemann, M. (2020) · npj Digital Medicine · doi:10.1038/s41746-020-0305-8 · Cited by 85
Using a smartwatch and smartphone to assess early Parkinson’s disease in the WATCH-PD study
Adams, J. L., Kangarloo, T., Tracey, B., O’Donnell, P., Volfson, D., Latzman, R. D., Zach, N., Alexander, R., Bergethon, P., Cosman, J., et al. (2023) · npj Parkinson's Disease · doi:10.1038/s41531-023-00497-x · Cited by 98
Self-citationRoussos, G., Herrero, T. R., Hill, D. L., Dowling, A. V., L. T. M. Müller, M., Evers, L. J. W., Burton, J., Derungs, A., Fisher, K., Kilambi, K. P., et al. (2022) · npj Digital Medicine · doi:10.1038/s41746-022-00643-4 · Cited by 28
Self-citationPatients' perspective on digital technologies in advanced genitourinary cancers
Rodler, S., Buchner, A., Stief, C. G., Heinemann, V., Staehler, M., & Casuscelli, J. (2021) · Clinical Genitourinary Cancer · doi:10.1016/j.clgc.2020.03.018 · Cited by 27
Reliability and Validity of Smartphone Cognitive Testing for Frontotemporal Lobar Degeneration
Staffaroni, A. M., Clark, A. L., Taylor, J. C., Heuer, H. W., Sanderson-Cimino, M., Wise, A. B., Dhanam, S., Cobigo, Y., Wolf, A., Manoochehri, M., et al. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.4266 · Cited by 28
Taylor, J. C., Heuer, H. W., Clark, A. L., Wise, A. B., Manoochehri, M., Forsberg, L., Mester, C., Rao, M., Brushaber, D., Kramer, J., et al. (2023) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1002/dad2.12423 · Cited by 20
Metadata
- Authors
- Zhan, A., Mohan, S., Tarolli, C., Schneider, R. B., Adams, J. L., Sharma, S., Elson, M. J., Spear, K. L., Glidden, A. M., Little, M. A., Terzis, A., Dorsey, E. R., & Saria, S.
- Venue
- JAMA Neurology
- Publisher
- American Medical Association (AMA)
- Published
- 2018-07-01
- Volume
- 75
- Issue
- 7
- Pages
- 876
- ISSN
- 2168-6149 (ISSN-L)
- OpenAlex
- W2791600159
- Cited by
- 381
- References
- 18
- FWCI
- 26.23
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.